Joel Tadman runs through the 10 biggest problems only golfers can relate to. Whether it's temporary greens or leaving a club behind on the previous hole, we know how frustrating certain things can be ...

Mizuho lowered the firm’s price target on ResMed (RMD) to $300 from $310 and keeps an Outperform rating on the shares following the fiscal Q1 report. The firm says GLP-1s are not presenting a headwind ...

Post-US/EU sanctions, energy markets aren’t panicking, there’s other supply & India’s macroeconomy can easily adjust In a change in tactics to end the Russia-Ukraine war, US has blacklisted two ...

An analysis of foodborne outbreak data collection in Austria has found issues with completeness and consistency. A report published by the European Food Safety Authority (EFSA) shared results of a ...

A third of Brits say their sleep schedule isn't aligned with their partners - fuelling a rise in 'sleep divorces' where people sleep in separate beds. 31% of Brits aren't aligned with their partner's ...

In a report released today, Suraj Kalia from Oppenheimer maintained a Hold rating on Resmed. The company’s shares closed yesterday at $252.26. Take advantage of TipRanks Premium at 50% off! Unlock ...